Wednesday, July 8, 2026

pharma · Hematologic Malignancies · Solid Tumor, Adult

Farmatek

Farmatek clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Aydınlı - KOSB Mah. Tuzla Kimya Sanayicileri Org. San. Böl. Analitik Cad. No:90 Tuzla, Istanbul, TR, JP HQ
1994 Founded
14 Employees
PMDA registrant Type
Company details
Status
Public
HQ
Aydınlı - KOSB Mah. Tuzla Kimya Sanayicileri Org. San. Böl. Analitik Cad. No:90 Tuzla, Istanbul, TR, JP
Founded
1994
Employees
14
Programs
26
Drugs
14
Patents
53
Intelligence · Clinical Programs

Farmatek projects

0 ClinicalTrials.gov programs sponsored by Farmatek.

Farmatek has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Farmatek have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.